8-K/A: Know Labs Amends 8-K Filing to Correct Item Reference After Annual Meeting

Know Labs has amended its original 8-K filing to correct an item reference, with no changes to the original disclosure regarding the results of its 2024 Annual Meeting of Stockholders.

Summary

• Know Labs filed an amendment to its original 8-K report to correct a tagging error, changing the reference from Item 8.01 to Item 5.07.
• The amendment does not alter any of the information disclosed in the original filing.
• The original filing detailed the results of the 2024 Annual Meeting of Stockholders held on September 26, 2024.
• At the meeting, seven directors were elected to the board, BPM LLP was ratified as the independent auditor, and the issuance of shares related to a Securities Purchase Agreement with Lind Global Fund II LP was authorized.
• Additionally, the compensation of the company's named executive officers was approved in a non-binding advisory vote.
• A total of 86,777,171 shares were eligible to vote, with proxies representing 56,964,556 shares, or 65.6% of the total shareholders.

Sentiment

Score: 7

Explanation: The document primarily reports on routine corporate governance matters, with no significant positive or negative surprises. The need for an amendment is a minor negative, but the overall tone is neutral to slightly positive due to the successful completion of the annual meeting.

Positives

• The company successfully held its 2024 Annual Meeting of Stockholders.
• All proposed resolutions were approved by shareholders.
• A significant portion of shareholders (65.6%) were represented by proxies at the meeting.

Negatives

• The company had to amend its original 8-K filing due to a tagging error.

Risks

• The need to amend the filing indicates a potential weakness in internal controls or processes.
• The company needs to ensure accurate reporting in future filings to maintain investor confidence.

Management Comments

• Ronald P. Erickson, Chairman of the Board, signed the report on behalf of the company.

Industry Context

This filing is a standard corporate governance procedure for a publicly traded company, reflecting the results of its annual shareholder meeting. The company's actions are consistent with regulatory requirements for public companies.

Comparison to Industry Standards

• The election of directors and ratification of auditors are standard practices for publicly traded companies, similar to companies like Masimo Corporation and Dexcom, which also hold annual shareholder meetings.
• The authorization of shares related to a securities purchase agreement is a common financing method, comparable to similar agreements used by other small-cap companies in the medical technology sector.
• The level of shareholder participation, with 65.6% of shares represented by proxies, is within the typical range for annual meetings, although higher participation is generally viewed more favorably.

Stakeholder Impact

• Shareholders have voted on key governance matters, including the election of directors and the ratification of the auditor.
• The authorization of shares related to the Lind agreement may have a dilutive effect on existing shareholders.

Next Steps

• The company will continue to operate under the newly elected board of directors.
• BPM LLP will serve as the independent registered public accounting firm for the fiscal year ending September 30, 2024.

Key Dates

Keywords

Annual Meeting, Stockholders, Board of Directors, Auditor, BPM LLP, Securities Purchase Agreement, Lind Global Fund II LP, Executive Compensation, Proxy Vote, 8-K Filing